284 related articles for article (PubMed ID: 11006024)
1. Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis.
Zanetta GM; Webb MJ; Li H; Keeney GL
Gynecol Oncol; 2000 Oct; 79(1):18-22. PubMed ID: 11006024
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy and risk of epithelial ovarian cancer.
Purdie DM; Bain CJ; Siskind V; Russell P; Hacker NF; Ward BG; Quinn MA; Green AC
Br J Cancer; 1999 Oct; 81(3):559-63. PubMed ID: 10507786
[TBL] [Abstract][Full Text] [Related]
3. Endometrioid adenocarcinoma arising from endometriosis of the mesenterium of the sigmoid colon.
Kawate S; Takeyoshi I; Ikota H; Numaga Y; Sunose Y; Morishita Y
Jpn J Clin Oncol; 2005 Mar; 35(3):154-7. PubMed ID: 15741306
[TBL] [Abstract][Full Text] [Related]
4. Endometriosis and the development of malignant tumours of the pelvis. A review of literature.
Van Gorp T; Amant F; Neven P; Vergote I; Moerman P
Best Pract Res Clin Obstet Gynaecol; 2004 Apr; 18(2):349-71. PubMed ID: 15157647
[TBL] [Abstract][Full Text] [Related]
5. Endometrioid adenocarcinoma 13 years after total abdominal hysterectomy and bilateral salpingo-oophorectomy.
Al-Talib A; Gilbert L; Arseneau J
Saudi Med J; 2008 Jul; 29(7):1044-7. PubMed ID: 18626539
[TBL] [Abstract][Full Text] [Related]
6. Endometrioid adenocarcinoma of the ovary and endometriosis.
Valenzuela P; Ramos P; Redondo S; Cabrera Y; Alvarez I; Ruiz A
Eur J Obstet Gynecol Reprod Biol; 2007 Sep; 134(1):83-6. PubMed ID: 16844279
[TBL] [Abstract][Full Text] [Related]
7. Malignancy arising in endometriosis associated with unopposed estrogen replacement.
Reimnitz C; Brand E; Nieberg RK; Hacker NF
Obstet Gynecol; 1988 Mar; 71(3 Pt 2):444-7. PubMed ID: 3279356
[TBL] [Abstract][Full Text] [Related]
8. Ovarian endometriosis associated with ovarian cancer and endometrial-endocervical polyps.
Kontoravdis A; Augoulea A; Lambrinoudaki I; Christodoulakos G; Tzortziotis D; Grammatikakis I; Kontoravdis N; Creatsas G
J Obstet Gynaecol Res; 2007 Jun; 33(3):294-8. PubMed ID: 17578358
[TBL] [Abstract][Full Text] [Related]
9. A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis.
Chew S; Tham KF; Ratnam SS
Singapore Med J; 1997 Jul; 38(7):289-91. PubMed ID: 9339094
[TBL] [Abstract][Full Text] [Related]
10. Noncontraceptive estrogen use and the occurrence of ovarian cancer.
Weiss NS; Lyon JL; Krishnamurthy S; Dietert SE; Liff JM; Daling JR
J Natl Cancer Inst; 1982 Jan; 68(1):95-8. PubMed ID: 6948131
[TBL] [Abstract][Full Text] [Related]
11. Cancer and endometriosis: do we need to be concerned?
Martin DC
Semin Reprod Endocrinol; 1997; 15(3):319-24. PubMed ID: 9383841
[TBL] [Abstract][Full Text] [Related]
12. [Endometriosis and malignoma].
Ulrich U; Richter O; Wardelmann E; Valter M; Schmutzler R; Sillem M; Possover M; Mallmann P
Zentralbl Gynakol; 2003; 125(7-8):239-42. PubMed ID: 14505256
[TBL] [Abstract][Full Text] [Related]
13. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps.
Giordano G; Gnetti L; Merisio C; Melpignano M
Maturitas; 2007 Feb; 56(2):190-7. PubMed ID: 16963204
[TBL] [Abstract][Full Text] [Related]
15. Hormonal carcinogenesis and socio-biological development factors in endometrial cancer: a clinical review.
Tinelli A; Vergara D; Martignago R; Leo G; Malvasi A; Tinelli R
Acta Obstet Gynecol Scand; 2008; 87(11):1101-13. PubMed ID: 18607816
[TBL] [Abstract][Full Text] [Related]
16. Ovarian endometrioid carcinoma and endometriosis developing in a postmenopausal breast cancer patient during tamoxifen therapy: a case report and review of the literature.
Cohen I; Altaras MM; Lew S; Tepper R; Beyth Y; Ben-Baruch G
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):443-7. PubMed ID: 7835785
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathological features of malignant ovarian neoplasms arising from ovarian endometriosis: a report of 26 cases].
Qu Y; Wang L; Zhu H
Zhonghua Fu Chan Ke Za Zhi; 2001 Aug; 36(8):470-2. PubMed ID: 11758181
[TBL] [Abstract][Full Text] [Related]
19. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer.
Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J
Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163
[TBL] [Abstract][Full Text] [Related]
20. Estrogens reduce and withdrawal of estrogens increase risk of microsatellite instability-positive colon cancer.
Slattery ML; Potter JD; Curtin K; Edwards S; Ma KN; Anderson K; Schaffer D; Samowitz WS
Cancer Res; 2001 Jan; 61(1):126-30. PubMed ID: 11196149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
